Novo Nordisk A/S ADR (NY: NVO )

140.80 +0.43 (+0.31%)
Official Closing Price Updated: 7:00 PM EDT, Jun 18, 2024 Add to My Watchlist

Other Filings

Form 6-K
Source: SEC/Edgar
October 10, 2011
Form 6-K
Source: SEC/Edgar
October 03, 2011
Form 6-K
Source: SEC/Edgar
September 29, 2011
Form 6-K
Source: SEC/Edgar
September 26, 2011
Form 6-K
Source: SEC/Edgar
September 25, 2011
Form 6-K
Source: SEC/Edgar
September 18, 2011
Form 6-K
Source: SEC/Edgar
September 18, 2011
Form 6-K
Source: SEC/Edgar
September 05, 2011
Form 6-K
Source: SEC/Edgar
August 29, 2011
Form 6-K
Source: SEC/Edgar
August 22, 2011
Form 6-K
Source: SEC/Edgar
August 11, 2011
Form 6-K
Source: SEC/Edgar
August 10, 2011
Form 6-K
Source: SEC/Edgar
August 10, 2011
Form 6-K
Source: SEC/Edgar
August 10, 2011
Form 6-K
Source: SEC/Edgar
August 08, 2011
Form 6-K
Source: SEC/Edgar
August 08, 2011
Form 6-K
Source: SEC/Edgar
August 07, 2011
Form 6-K
Source: SEC/Edgar
August 03, 2011
Form 6-K
Source: SEC/Edgar
August 03, 2011
Form 6-K
Source: SEC/Edgar
July 24, 2011
Form 6-K
Source: SEC/Edgar
July 19, 2011
Form 6-K
Source: SEC/Edgar
July 11, 2011
Form 6-K
Source: SEC/Edgar
July 04, 2011
Form 11-K
Source: SEC/Edgar
June 28, 2011
Form 11-K
Source: SEC/Edgar
June 28, 2011
Form 6-K
Source: SEC/Edgar
June 27, 2011
Form 6-K
Source: SEC/Edgar
June 19, 2011
Form 6-K
Source: SEC/Edgar
June 16, 2011
Form 6-K
Source: SEC/Edgar
June 13, 2011
Form 6-K
Source: SEC/Edgar
June 06, 2011
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.